Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Best Momentum Stocks to Buy for February 13th

In This Article:

Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, February 13th:

Veracyte, Inc. VCYT: This diagnostics company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.4% over the last 60 days.

Veracyte, Inc. Price and Consensus

Veracyte, Inc. Price and Consensus
Veracyte, Inc. Price and Consensus

Veracyte, Inc. price-consensus-chart | Veracyte, Inc. Quote

Veracyte’s shares gained 2.2% over the last three months compared with the S&P 500’s advance of 1%. The company possesses a Momentum Score  of A.

Veracyte, Inc. Price

Veracyte, Inc. Price
Veracyte, Inc. Price

Veracyte, Inc. price | Veracyte, Inc. Quote

Northern Trust Corporation NTRS: This wealth management company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.7% over the last 60 days.

Northern Trust Corporation Price and Consensus

Northern Trust Corporation Price and Consensus
Northern Trust Corporation Price and Consensus

Northern Trust Corporation price-consensus-chart | Northern Trust Corporation Quote

Northern Trust’s shares gained 3.05% over the past three months compared with the S&P 500’s advance of 1%. The company possesses a Momentum Score of A.

Northern Trust Corporation Price

Northern Trust Corporation Price
Northern Trust Corporation Price

Northern Trust Corporation price | Northern Trust Corporation Quote

 

See the full list of top ranked stocks here

 

Learn more about the Momentum score and how it is calculated here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Northern Trust Corporation (NTRS) : Free Stock Analysis Report

Veracyte, Inc. (VCYT) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research